Stock Information
Incyte Corp (INCY)
Ticker Symbol: INCY
Exchange: NASDAQ
Sector: Biotechnology
Market Cap: $22,733.42 mil
Piotroski score: 6
PE Ratio: 16.419
EPS (TTM): 7.0731
Revenue (TTM): $25.92 M
Dividend Yield: N/A%
ROE: 29.2%
Latest News
-
Incyte (INCY) Reports Full Latarcibart Data And Buys Vega Therapeutics
Sun, Jul 26, 2026 1:11 AM
-
Incyte Gears Up to Report Q2 Earnings: Is a Beat Around the Corner?
Fri, Jul 24, 2026 2:38 PM
-
INCYTE CORP (NASDAQ:INCY) Screens as a High Growth Momentum Stock with a Breakout Setup
Fri, Jul 24, 2026 10:40 AM
-
JP Morgan Maintains Neutral on Incyte, Raises Price Target to $110
Thu, Jul 23, 2026 2:41 PM
-
Morgan Stanley Maintains Equal-Weight on Incyte, Raises Price Target to $104
Thu, Jul 23, 2026 2:02 PM
-
Earnings Preview: LENZ Therapeutics, Inc. (LENZ) Q2 Earnings Expected to Decline
Wed, Jul 22, 2026 2:00 PM
-
HALO Inks Deal With INCY to Support Cancer Therapy Development
Tue, Jul 21, 2026 2:38 PM
-
Incyte (INCY) Reports Next Week: Wall Street Expects Earnings Growth
Tue, Jul 21, 2026 2:00 PM
-
Tracking Baker Brothers Portfolio: Q1 2026 Update
Tue, Jul 21, 2026 1:26 PM
-
HC Wainwright & Co. Reiterates Buy on Incyte, Maintains $140 Price Target
Tue, Jul 21, 2026 6:30 AM
Key Financials
Financial data not available